Mia Bendix - Search Results

Year	Number of Results
2013	2
2014	1
2015	1
2016	1
2017	1
2018	1
2020	1
2021	1
2023	1
2024	0

1

Current, experimental, and future treatments in inflammatory bowel disease: a clinical review.

Hvas CL, Bendix M, Dige A, Dahlerup JF, Agnholt J. Hvas CL, et al. Among authors: bendix m. Immunopharmacol Immunotoxicol. 2018 Dec;40(6):446-460. doi: 10.1080/08923973.2018.1469144. Epub 2018 May 10. Immunopharmacol Immunotoxicol. 2018. PMID: 29745777 Review.

2

Fecal Supernatants from Patients with Crohn's Disease Induce Inflammatory Alterations in M2 Macrophages and Fibroblasts.

Gorreja F, Bendix M, Rush STA, Maasfeh L, Savolainen O, Dige A, Agnholt J, Öhman L, Magnusson MK. Gorreja F, et al. Among authors: bendix m. Cells. 2023 Dec 27;13(1):60. doi: 10.3390/cells13010060. Cells. 2023. PMID: 38201264 Free PMC article.

3

Vitamin D increases programmed death receptor-1 expression in Crohn's disease.

Bendix M, Greisen S, Dige A, Hvas CL, Bak N, Jørgensen SP, Dahlerup JF, Deleuran B, Agnholt J. Bendix M, et al. Oncotarget. 2017 Apr 11;8(15):24177-24186. doi: 10.18632/oncotarget.15489. Oncotarget. 2017. PMID: 28412753 Free PMC article.

4

Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study.

Hvas CL, Dige A, Bendix M, Wernlund PG, Christensen LA, Dahlerup JF, Agnholt J. Hvas CL, et al. Among authors: bendix m. Eur J Clin Invest. 2016 Jun;46(6):555-63. doi: 10.1111/eci.12634. Eur J Clin Invest. 2016. PMID: 27090817 Clinical Trial.

5

Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn's Disease during One-Year Follow-Up.

Bendix M, Dige A, Jørgensen SP, Dahlerup JF, Bibby BM, Deleuran B, Agnholt J. Bendix M, et al. Nutrients. 2021 Mar 26;13(4):1083. doi: 10.3390/nu13041083. Nutrients. 2021. PMID: 33810258 Free PMC article.

6

25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease.

Bartels LE, Jørgensen SP, Bendix M, Hvas CL, Agnholt J, Agger R, Dahlerup JF. Bartels LE, et al. Among authors: bendix m. Inflammopharmacology. 2013 Apr;21(2):177-86. doi: 10.1007/s10787-012-0168-y. Epub 2013 Jan 23. Inflammopharmacology. 2013. PMID: 23341164

7

Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.

Bjerg Christensen A, Dige A, Vad-Nielsen J, Brinkmann CR, Bendix M, Østergaard L, Tolstrup M, Søgaard OS, Rasmussen TA, Randel Nyengaard J, Agnholt J, Denton PW. Bjerg Christensen A, et al. Among authors: bendix m. Mediators Inflamm. 2015;2015:120605. doi: 10.1155/2015/120605. Epub 2015 Dec 1. Mediators Inflamm. 2015. PMID: 26696749 Free PMC article. Clinical Trial.

8

Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab.

Bendix M, Dige A, Jørgensen SP, Dahlerup JF, Bibby BM, Deleuran B, Agnholt J. Bendix M, et al. Nutrients. 2020 Nov 30;12(12):3699. doi: 10.3390/nu12123699. Nutrients. 2020. PMID: 33266022 Free PMC article. Clinical Trial.

9

Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients.

Bartels LE, Bendix M, Hvas CL, Jørgensen SP, Agnholt J, Agger R, Dahlerup JF. Bartels LE, et al. Among authors: bendix m. Inflammopharmacology. 2014 Apr;22(2):95-103. doi: 10.1007/s10787-013-0197-1. Epub 2013 Dec 29. Inflammopharmacology. 2014. PMID: 24374976 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year